Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration.
Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration.
复制标题
肿瘤源性外泌体蛋白O型酪氨酸磷酸酶受体极化巨噬细胞抑制乳腺肿瘤细胞侵袭和迁移
DOI:
10.3389/fcell.2021.703537
复制
发表时间:
2021
影响因子:
5.5
通讯作者:
Zhang H
中科院分区:
文献类型:
--
作者:
Dong H;Xie C;Jiang Y;Li K;Lin Y;Pang X;Xiong X;Zheng J;Ke X;Chen Y;Li Y;Zhang H
Tumor-derived exosomes, containing multiple nucleic acids and proteins, have been implicated to participate in the interaction between tumor cells and microenvironment. However, the functional involvement of phosphatases in tumor-derived exosomes is not fully understood. We and others previously demonstrated that protein tyrosine phosphatase receptor type O (PTPRO) acts as a tumor suppressor in multiple cancer types. In addition, its role in tumor immune microenvironment remains elusive. Bioinformatical analyses revealed that PTPRO was closely associated with immune infiltration, and positively correlated to M1-like macrophages, but negatively correlated to M2-like macrophages in breast cancer tissues. Co-cultured with PTPRO-overexpressing breast cancer cells increased the proportion of M1-like tumor-associated macrophages (TAMs) while decreased that of M2-like TAMs. Further, we observed that tumor-derived exosomal PTPRO induced M1-like macrophage polarization, and regulated the corresponding functional phenotypes. Moreover, tumor cell-derived exosomal PTPRO inhibited breast cancer cell invasion and migration, and inactivated STAT signaling in macrophages. Our data suggested that exosomal PTPRO inhibited breast cancer invasion and migration by modulating macrophage polarization. Anti-tumoral effect of exosomal PTPRO was mediated by inactivating STAT family in macrophages. These findings highlight a novel mechanism of tumor invasion regulated by tumor-derived exosomal tyrosine phosphatase, which is of translational potential for the therapeutic strategy against breast cancer.
登录
查看更多内容
影响因子:
7.4
作者:
Huang YT;Li FF;Ke C;Li Z;Li ZT;Zou XF;Zheng XX;Chen YP;Zhang H
通讯作者:
Zhang H
影响因子:
9
作者:
通讯作者:
--
影响因子:
8
作者:
Dong H;Ma L;Gan J;Lin W;Chen C;Yao Z;Du L;Zheng L;Ke C;Huang X;Song H;Kumar R;Yeung SC;Zhang H
通讯作者:
Zhang H
影响因子:
0.9
作者:
Gan J;Zhang H
通讯作者:
Zhang H
DOI:
10.1038/nrclinonc.2016.217
发表时间:
2017-07
期刊:
Nature reviews. Clinical oncology
影响因子:
--
作者:
Mantovani A;Marchesi F;Malesci A;Laghi L;Allavena P
通讯作者:
Allavena P